Literature DB >> 17153932

Mutagenesis of human p53 tumor suppressor gene sequences in embryonic fibroblasts of genetically-engineered mice.

Zhipei Liu1, Djeda Belharazem, Karl Rudolf Muehlbauer, Tatiana Nedelko, Yuri Knyazev, Monica Hollstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17153932     DOI： 10.1007/978-0-387-34504-8_3

Source DB:  PubMed          Journal:  Genet Eng (N Y)        ISSN： 0196-3716


× No keyword cloud information.
  10 in total

1.  Modulation of N-Methyl-N-nitrosourea Mutagenesis in Mouse Embryo Fibroblasts Derived from the gpt Delta Mouse by an Inhibitor of the O6-Methylguanine Methyltransferase, MGMT.

Authors:  Pennapa Thongararm; Bogdan I Fedeles; Sakunchai Khumsubdee; Amanda L Armijo; Lina Kim; Apinya Thiantanawat; Jeerawan Promvijit; Panida Navasumrit; Mathuros Ruchirawat; Robert G Croy; John M Essigmann
Journal:  Chem Res Toxicol       Date:  2019-12-24       Impact factor: 3.739

2.  TP53 mutations induced by BPDE in Xpa-WT and Xpa-Null human TP53 knock-in (Hupki) mouse embryo fibroblasts.

Authors:  Jill E Kucab; Harry van Steeg; Mirjam Luijten; Heinz H Schmeiser; Paul A White; David H Phillips; Volker M Arlt
Journal:  Mutat Res       Date:  2015-01-30       Impact factor: 2.433

3.  Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts.

Authors:  Annette M Krais; Karl-Rudolf Mühlbauer; Jill E Kucab; Helena Chinbuah; Michael G Cornelius; Quan-Xiang Wei; Monica Hollstein; David H Phillips; Volker M Arlt; Heinz H Schmeiser
Journal:  Toxicol In Vitro       Date:  2014-09-16       Impact factor: 3.500

4.  TP53 and lacZ mutagenesis induced by 3-nitrobenzanthrone in Xpa-deficient human TP53 knock-in mouse embryo fibroblasts.

Authors:  Jill E Kucab; Edwin P Zwart; Harry van Steeg; Mirjam Luijten; Heinz H Schmeiser; David H Phillips; Volker M Arlt
Journal:  DNA Repair (Amst)       Date:  2015-12-08

Review 5.  Base changes in tumour DNA have the power to reveal the causes and evolution of cancer.

Authors:  M Hollstein; L B Alexandrov; C P Wild; M Ardin; J Zavadil
Journal:  Oncogene       Date:  2016-06-06       Impact factor: 9.867

6.  Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing.

Authors:  H Huskova; M Ardin; A Weninger; K Vargova; S Barrin; S Villar; M Olivier; T Stopka; Z Herceg; M Hollstein; J Zavadil; M Korenjak
Journal:  Oncogene       Date:  2017-07-10       Impact factor: 9.867

7.  Nutlin-3a selects for cells harbouring TP53 mutations.

Authors:  Jill E Kucab; Monica Hollstein; Volker M Arlt; David H Phillips
Journal:  Int J Cancer       Date:  2016-11-22       Impact factor: 7.396

8.  Characterising Mutational Spectra of Carcinogens in the Tumour Suppressor Gene TP53 Using Human TP53 Knock-in (Hupki) Mouse Embryo Fibroblasts.

Authors:  Lisa Hölzl-Armstrong; Jill E Kucab; Michael Korenjak; Mirjam Luijten; David H Phillips; Jiri Zavadil; Volker M Arlt
Journal:  Methods Protoc       Date:  2019-11-13

9.  The genome as a record of environmental exposure.

Authors:  Serena Nik-Zainal; Jill E Kucab; Sandro Morganella; Dominik Glodzik; Ludmil B Alexandrov; Volker M Arlt; Annette Weninger; Monica Hollstein; Michael R Stratton; David H Phillips
Journal:  Mutagenesis       Date:  2015-10-06       Impact factor: 3.000

10.  Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72.

Authors:  M Reinbold; J-L Luo; T Nedelko; B Jerchow; M E Murphy; C Whibley; Q Wei; M Hollstein
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.